News
Vincent Boucher, widely recognized as one of the earliest pioneers in AGI (artificial general intelligence), today announced ...
While bidding optimization is one of the most powerful AI use cases in the ad industry’s tool kit, it remains underutilized.
Vincent Boucher today announced the evolution of (AGI Alpha), a blockchain-native AGI-First platform designed to redefine how intelligence is orchestrated, shared, and monetized globally ...
Absci's AI-driven drug discovery platform, its potential, challenges, and strategic partnerships. Read here for an investment analysis of ABSI stock.
Healthcare AI technology platforms are experiencing unprecedented adoption as diagnostic markets surge at 22% annually across imaging, drug discovery, and clinical workflows to combat critical ...
An overview of algorithm design and analysis. Topics include analysis of algorithms for traversing graphs and trees, searching and sorting, recursion, dynamic programming, and approximation, as well ...
Tech pioneers Dave Copps and Taylor Shead explain how artificial intelligence is transforming the way companies operate, ...
This paper investigates the application of recently proposed practical subarray (SA)-based hybrid beamforming (HBF) architectures-implemented entirely with passive beamforming networks and ...
The control of wireless power transfersystems with an active rectifier can be implemented on the secondary side, which avoids the need for real-time wireless communication between the primary and ...
5don MSN
If You'd Invested $1,000 in Recursion Pharmaceuticals 4 Years Ago, Here's How Much You'd Have Today
Recursion Pharmaceuticals (RXRX 0.02%), a biotech company focused on artificial intelligence (AI), went public in April 2021. This was before ChatGPT, before AI became the hottest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results